 Jeffrey Jacot
Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 17 | 2025 | 546 | 4.480 |
Why?
| | Amniotic Fluid | 10 | 2025 | 79 | 3.920 |
Why?
| | Tissue Engineering | 7 | 2023 | 438 | 2.270 |
Why?
| | Induced Pluripotent Stem Cells | 6 | 2025 | 273 | 2.250 |
Why?
| | Hydrogels | 9 | 2023 | 701 | 2.030 |
Why?
| | Fibrin | 6 | 2023 | 84 | 1.940 |
Why?
| | Polyurethanes | 3 | 2021 | 38 | 1.930 |
Why?
| | Stem Cells | 7 | 2026 | 630 | 1.910 |
Why?
| | Tissue Scaffolds | 4 | 2023 | 221 | 1.890 |
Why?
| | Myocardium | 7 | 2026 | 935 | 1.530 |
Why?
| | Cell Differentiation | 13 | 2026 | 2050 | 1.500 |
Why?
| | Heart | 3 | 2025 | 626 | 1.300 |
Why?
| | Chitosan | 3 | 2017 | 39 | 1.250 |
Why?
| | Mechanotransduction, Cellular | 2 | 2025 | 121 | 1.110 |
Why?
| | Materials Testing | 3 | 2021 | 345 | 1.090 |
Why?
| | Polyethylene Glycols | 5 | 2023 | 649 | 0.950 |
Why?
| | Heart Ventricles | 4 | 2021 | 756 | 0.910 |
Why?
| | Ventricular Function, Left | 2 | 2019 | 544 | 0.810 |
Why?
| | Bioreactors | 1 | 2023 | 50 | 0.780 |
Why?
| | Heart-Assist Devices | 2 | 2019 | 568 | 0.680 |
Why?
| | Human Umbilical Vein Endothelial Cells | 5 | 2023 | 104 | 0.670 |
Why?
| | Bioprosthesis | 1 | 2021 | 39 | 0.650 |
Why?
| | Pericardium | 2 | 2021 | 59 | 0.650 |
Why?
| | Polyesters | 3 | 2021 | 76 | 0.640 |
Why?
| | Stem Cell Transplantation | 1 | 2021 | 189 | 0.610 |
Why?
| | Endothelial Cells | 3 | 2021 | 878 | 0.580 |
Why?
| | Cardiac Output | 1 | 2019 | 179 | 0.580 |
Why?
| | Down Syndrome | 1 | 2025 | 525 | 0.570 |
Why?
| | Cells, Cultured | 9 | 2026 | 4151 | 0.560 |
Why?
| | Rats, Sprague-Dawley | 8 | 2019 | 2525 | 0.550 |
Why?
| | Cell Adhesion | 3 | 2014 | 451 | 0.550 |
Why?
| | Extracellular Matrix | 3 | 2025 | 563 | 0.550 |
Why?
| | Leukocytes, Mononuclear | 1 | 2021 | 574 | 0.540 |
Why?
| | Pluripotent Stem Cells | 1 | 2018 | 81 | 0.530 |
Why?
| | Electrocardiography | 3 | 2019 | 668 | 0.520 |
Why?
| | Animals | 24 | 2026 | 38106 | 0.520 |
Why?
| | Fetal Stem Cells | 1 | 2017 | 8 | 0.520 |
Why?
| | Silicon Dioxide | 1 | 2018 | 119 | 0.510 |
Why?
| | Ventricular Remodeling | 2 | 2019 | 278 | 0.500 |
Why?
| | Rats | 8 | 2021 | 5585 | 0.490 |
Why?
| | Membranes, Artificial | 1 | 2017 | 68 | 0.490 |
Why?
| | Embryonic Stem Cells | 2 | 2015 | 124 | 0.480 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 3 | 2016 | 80 | 0.480 |
Why?
| | Biocompatible Materials | 2 | 2020 | 429 | 0.430 |
Why?
| | Electric Conductivity | 1 | 2014 | 85 | 0.420 |
Why?
| | Nanotubes, Carbon | 1 | 2014 | 46 | 0.410 |
Why?
| | Osmium Tetroxide | 1 | 2013 | 1 | 0.400 |
Why?
| | Capillaries | 1 | 2015 | 125 | 0.400 |
Why?
| | Polymethyl Methacrylate | 1 | 2013 | 21 | 0.400 |
Why?
| | Electron Microscope Tomography | 1 | 2013 | 41 | 0.390 |
Why?
| | Coloring Agents | 1 | 2013 | 89 | 0.390 |
Why?
| | Neovascularization, Physiologic | 1 | 2015 | 193 | 0.390 |
Why?
| | Myocardial Contraction | 4 | 2018 | 293 | 0.380 |
Why?
| | Action Potentials | 1 | 2016 | 502 | 0.380 |
Why?
| | Wnt Signaling Pathway | 1 | 2015 | 212 | 0.380 |
Why?
| | Gap Junctions | 1 | 2013 | 67 | 0.360 |
Why?
| | Microvessels | 1 | 2013 | 97 | 0.360 |
Why?
| | Gelatin | 1 | 2012 | 56 | 0.360 |
Why?
| | Porosity | 3 | 2018 | 94 | 0.330 |
Why?
| | Fibroblasts | 1 | 2014 | 1028 | 0.280 |
Why?
| | Humans | 24 | 2026 | 145785 | 0.280 |
Why?
| | Cell Separation | 3 | 2015 | 306 | 0.270 |
Why?
| | Cell Proliferation | 3 | 2025 | 2514 | 0.270 |
Why?
| | Heart Valves | 2 | 2021 | 44 | 0.250 |
Why?
| | Saphenous Vein | 1 | 2006 | 37 | 0.240 |
Why?
| | Fatty Acid Transport Proteins | 1 | 2026 | 22 | 0.240 |
Why?
| | Endocardial Cushions | 1 | 2025 | 7 | 0.230 |
Why?
| | Angiotensin II | 1 | 2026 | 102 | 0.230 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2026 | 83 | 0.230 |
Why?
| | Amniocentesis | 1 | 2025 | 20 | 0.230 |
Why?
| | Cell Line | 2 | 2021 | 2823 | 0.230 |
Why?
| | Mice | 7 | 2026 | 18358 | 0.220 |
Why?
| | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2026 | 89 | 0.220 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2026 | 271 | 0.210 |
Why?
| | Troponin T | 2 | 2014 | 63 | 0.200 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2026 | 450 | 0.200 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2015 | 196 | 0.200 |
Why?
| | Disease Models, Animal | 3 | 2026 | 4568 | 0.200 |
Why?
| | Cell Shape | 2 | 2014 | 56 | 0.190 |
Why?
| | Water | 1 | 2006 | 448 | 0.190 |
Why?
| | Coculture Techniques | 2 | 2014 | 247 | 0.190 |
Why?
| | Substrate Specificity | 2 | 2016 | 387 | 0.190 |
Why?
| | Lipid Metabolism | 1 | 2026 | 529 | 0.180 |
Why?
| | Pregnancy | 3 | 2025 | 7216 | 0.180 |
Why?
| | Immunotherapy, Adoptive | 1 | 2026 | 343 | 0.180 |
Why?
| | Stress, Mechanical | 3 | 2010 | 494 | 0.180 |
Why?
| | Acrylic Resins | 2 | 2016 | 46 | 0.180 |
Why?
| | Cell Communication | 2 | 2014 | 327 | 0.170 |
Why?
| | Succinimides | 1 | 2021 | 21 | 0.170 |
Why?
| | Heart Failure | 1 | 2015 | 2326 | 0.170 |
Why?
| | Salinity | 1 | 2021 | 18 | 0.170 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 171 | 0.170 |
Why?
| | Solvents | 1 | 2021 | 112 | 0.160 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2026 | 883 | 0.160 |
Why?
| | Gene Expression Regulation | 3 | 2015 | 2601 | 0.160 |
Why?
| | Sodium Chloride | 1 | 2021 | 138 | 0.160 |
Why?
| | Cross-Linking Reagents | 1 | 2021 | 206 | 0.160 |
Why?
| | Animals, Newborn | 2 | 2013 | 896 | 0.160 |
Why?
| | Fibrinogen | 1 | 2021 | 180 | 0.150 |
Why?
| | Cell Survival | 2 | 2014 | 1105 | 0.150 |
Why?
| | Chemokines | 1 | 2021 | 217 | 0.150 |
Why?
| | Organ Culture Techniques | 1 | 2020 | 154 | 0.150 |
Why?
| | Bioengineering | 1 | 2018 | 20 | 0.140 |
Why?
| | Electrophysiological Phenomena | 1 | 2018 | 59 | 0.140 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2018 | 83 | 0.140 |
Why?
| | Swine | 1 | 2021 | 826 | 0.140 |
Why?
| | Tensile Strength | 2 | 2010 | 98 | 0.140 |
Why?
| | Delayed-Action Preparations | 1 | 2018 | 189 | 0.130 |
Why?
| | Wnt Proteins | 1 | 2018 | 133 | 0.130 |
Why?
| | Microscopy, Atomic Force | 2 | 2009 | 128 | 0.130 |
Why?
| | Nanog Homeobox Protein | 1 | 2017 | 12 | 0.130 |
Why?
| | Alzheimer Disease | 1 | 2024 | 630 | 0.130 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2017 | 19 | 0.130 |
Why?
| | Calcium | 2 | 2016 | 1192 | 0.130 |
Why?
| | Pregnancy Trimester, Second | 1 | 2017 | 85 | 0.130 |
Why?
| | Antigens, Surface | 1 | 2017 | 155 | 0.120 |
Why?
| | Mice, Nude | 1 | 2018 | 680 | 0.120 |
Why?
| | Proteoglycans | 1 | 2017 | 112 | 0.120 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 98 | 0.120 |
Why?
| | Elastic Modulus | 1 | 2016 | 121 | 0.120 |
Why?
| | Oncolytic Viruses | 1 | 2016 | 8 | 0.120 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 337 | 0.110 |
Why?
| | Patch-Clamp Techniques | 1 | 2016 | 289 | 0.110 |
Why?
| | Calcium Channels, L-Type | 1 | 2016 | 117 | 0.110 |
Why?
| | Batch Cell Culture Techniques | 1 | 2015 | 3 | 0.110 |
Why?
| | Adenoviridae | 1 | 2016 | 199 | 0.110 |
Why?
| | Transfection | 1 | 2017 | 927 | 0.110 |
Why?
| | Intestine, Small | 1 | 2015 | 167 | 0.100 |
Why?
| | Genetic Markers | 1 | 2015 | 338 | 0.100 |
Why?
| | Sus scrofa | 1 | 2014 | 65 | 0.100 |
Why?
| | Corrosion Casting | 1 | 2013 | 1 | 0.100 |
Why?
| | Compressive Strength | 1 | 2014 | 72 | 0.100 |
Why?
| | Diffusion Chambers, Culture | 1 | 2013 | 9 | 0.100 |
Why?
| | Heart Conduction System | 1 | 2014 | 96 | 0.100 |
Why?
| | Calsequestrin | 1 | 2013 | 8 | 0.100 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2014 | 328 | 0.100 |
Why?
| | Infant, Newborn | 1 | 2025 | 6465 | 0.100 |
Why?
| | Organ Specificity | 1 | 2014 | 309 | 0.100 |
Why?
| | Cardiovascular Abnormalities | 1 | 2013 | 15 | 0.100 |
Why?
| | Connexin 43 | 1 | 2013 | 36 | 0.090 |
Why?
| | Prosthesis Design | 1 | 2015 | 356 | 0.090 |
Why?
| | Regenerative Medicine | 1 | 2013 | 48 | 0.090 |
Why?
| | Rabbits | 1 | 2013 | 653 | 0.090 |
Why?
| | Female | 6 | 2025 | 79045 | 0.090 |
Why?
| | Myosin Heavy Chains | 1 | 2013 | 183 | 0.090 |
Why?
| | Endotoxins | 1 | 2012 | 217 | 0.090 |
Why?
| | Surface Properties | 1 | 2012 | 386 | 0.090 |
Why?
| | Tumor Microenvironment | 1 | 2016 | 735 | 0.080 |
Why?
| | Recovery of Function | 1 | 2015 | 716 | 0.080 |
Why?
| | Chromatography, Liquid | 1 | 2012 | 450 | 0.080 |
Why?
| | Signal Transduction | 2 | 2015 | 5226 | 0.080 |
Why?
| | Protein Transport | 1 | 2012 | 442 | 0.080 |
Why?
| | Cell Culture Techniques | 1 | 2013 | 375 | 0.080 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 675 | 0.070 |
Why?
| | Embryo, Mammalian | 1 | 2009 | 234 | 0.070 |
Why?
| | Models, Biological | 1 | 2016 | 1764 | 0.070 |
Why?
| | Flow Cytometry | 1 | 2012 | 1165 | 0.070 |
Why?
| | Cell Movement | 1 | 2012 | 963 | 0.070 |
Why?
| | Age Factors | 1 | 2015 | 3346 | 0.060 |
Why?
| | Nitric Oxide | 1 | 2012 | 892 | 0.060 |
Why?
| | Biomarkers | 1 | 2018 | 4302 | 0.060 |
Why?
| | Compliance | 1 | 2006 | 50 | 0.060 |
Why?
| | Antigens, Ly | 1 | 2026 | 46 | 0.060 |
Why?
| | Lung | 1 | 2020 | 4116 | 0.060 |
Why?
| | Male | 5 | 2026 | 73012 | 0.060 |
Why?
| | Elasticity | 1 | 2006 | 189 | 0.060 |
Why?
| | Myocardial Infarction | 1 | 2013 | 1211 | 0.060 |
Why?
| | Myofibroblasts | 1 | 2026 | 149 | 0.050 |
Why?
| | Adult | 2 | 2025 | 40882 | 0.050 |
Why?
| | Amyloidogenic Proteins | 1 | 2024 | 16 | 0.050 |
Why?
| | Cell Line, Tumor | 2 | 2026 | 3551 | 0.050 |
Why?
| | Fibrosis | 1 | 2026 | 561 | 0.050 |
Why?
| | Phenotype | 2 | 2026 | 3170 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2026 | 936 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2026 | 5995 | 0.050 |
Why?
| | Plasma | 1 | 2024 | 223 | 0.040 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2026 | 534 | 0.040 |
Why?
| | Neoplasms | 1 | 2016 | 2913 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2015 | 11794 | 0.040 |
Why?
| | Child, Preschool | 1 | 2015 | 11868 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2026 | 3130 | 0.040 |
Why?
| | Peptides | 1 | 2024 | 1000 | 0.030 |
Why?
| | Stromal Cells | 1 | 2016 | 121 | 0.030 |
Why?
| | Adolescent | 1 | 2015 | 22577 | 0.030 |
Why?
| | Mice, SCID | 1 | 2016 | 369 | 0.030 |
Why?
| | Child | 1 | 2015 | 22740 | 0.030 |
Why?
| | Aged | 1 | 2015 | 26217 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2016 | 508 | 0.030 |
Why?
| | Organoids | 1 | 2016 | 144 | 0.030 |
Why?
| | Sheep | 1 | 2015 | 876 | 0.020 |
Why?
| | Middle Aged | 1 | 2015 | 36309 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 920 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1898 | 0.020 |
Why?
| | Aging | 1 | 2018 | 1973 | 0.020 |
Why?
|
|
Jacot's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|